BD Pharmingen™ APC Rat Anti-Mouse CD8a (553035)

Cd8a; CD8 alpha chain; Ly-2; Lyt2; Lyt-2; Ly-35; Ly-B

反应种属:Mouse
抗原名称:CD8A
应用:FCM
标记:APC

用户验证的应用

经验证应用

项目详情
ApplicationFlow cytometry (Routinely Tested)

详细信息

免疫原Mouse Spleen Cells or Thymocyte Membranes
宿主/亚型Rat LOU, also known as Louvain, LOU/C, LOU/M IgG2a, κ
抗体类型Monoclonal
产品类型Antibody
克隆号53-6.7
偶联物APC
浓度0.2 mg/ml
监管状态RUO
储存缓冲液Aqueous buffered solution containing ≤0.09% sodium azide.
储存条件Store undiluted at 4°C and protected from prolonged exposure to light. Do not freeze.
纯化方式affinity chromatography
RRIDAB_398527
最大激发波长651 nm
最大发射波长660 nm

制备与储存

Store undiluted at 4°C and protected from prolonged exposure to light. Do not freeze. The monoclonal antibody was purified from tissue culture supernatant or ascites by affinity chromatography. The antibody was conjugated to APC under optimum conditions, and unconjugated antibody and free APC were removed.

荧光格式说明

Allophycocyanin (APC), is part of the BD family of phycobiliprotein dyes. This fluorochrome is a multimeric fluorescent phycobiliprotein with excitation maximum (Ex Max) of 651 nm and an emission maximum (Em Max) at 660 nm. APC is designed to be excited by the Red (627-640 nm) laser and detected using an optical filter centered near 660 nm (e.g., a 660/20 nm bandpass filter). Please ensure that your instrument’s configurations (lasers and optical filters) are appropriate for this dye.

产品提示

Since applications vary, each investigator should titrate the reagent to obtain optimal results., An isotype control should be used at the same concentration as the antibody of interest., Caution: Sodium azide yields highly toxic hydrazoic acid under acidic conditions. Dilute azide compounds in running water before discarding to avoid accumulation of potentially explosive deposits in plumbing., For fluorochrome spectra and suitable instrument settings, please refer to our Multicolor Flow Cytometry web page at www.bdbiosciences.com/colors., This APC-conjugated reagent can be used in any flow cytometer equipped with a dye, HeNe, or red diode laser., Please refer to www.bdbiosciences.com/us/s/resources for technical protocols.

背景信息

The 53-6.7 monoclonal antibody specifically binds to the 38 kDa α and 34 kDa α' chains of the CD8 differentiation antigen (Ly-2 or Lyt-2) of all mouse strains tested. The CD8 α and α' chains (CD8a) form heterodimers with the CD8 β chain (CD8b, Ly-3, or Lyt-3) on the surface of most thymocytes. A subpopulation of mature T lymphocytes (i.e., MHC class I-restricted T cells, including most T suppressor/cytotoxic cells) expresses almost exclusively the CD8 αβ heterodimer. Subsets of γδ TCR-bearing T cells, intestinal intrapithelial lymphocytes, and dendritic cells express CD8a without CD8b. It has been suggested that the expression of the CD8a/CD8b heterodimer is restricted to T lymphocytes which matured in the thymus or in an extrathymic environment that had been influenced by thymus-initiated neuroendocrine signals. CD8 is an antigen coreceptor on the T-cell surface which interacts with MHC class I molecules on antigen-presenting cells or epithelial cells. It participates in T-cell activation through its association with the T-cell receptor complex and protein tyrosine kinase lck (p56 [lck]). The CD8 α and α' chains arise from alternatively spliced messengers of a single CD8a gene. The longer α form associates with p56 [lck] via a CXCP motif in its cytoplasmic domain, which it shares with CD4, but not with CD8b. The truncated α' chain is unable to associate with p56 [lck], and it may function to attenuate the CD8-mediated costimulatory signal during intrathymic T-cell maturation. In vivo and in vitro treatment with 53-6.7 mAb has reportedly been effective at depleting CD8+ peripheral T lymphocytes. The 53-6.7 antibody has also been reported to cross-react with CD8 α- and α'-like polypeptides on subsets of thymic and peripheral lymphocytes in the Egyptian toad, Bufo regularis .

文献引用 (133)

Microbial cancer immunotherapy reprograms hematopoiesis to enhance myeloid-driven anti-tumor immunity

微生物癌症免疫疗法通过重编程造血过程来增强髓系驱动的抗肿瘤免疫力。

Andrew W Daman ,Anthony C Antonelli ,Gil Redelman-Sidi ,Lucinda Paddock ,Shireen Khayat ,Mythili Ketavarapu ,Jin Gyu Cheong ,Leonardo F Jurado ,Anna Benjamin ,Song Jiang ,Dughan Ahimovic ,Victoria R Lawless ,Michael J Bale ,Oleg Loutochin ,Victor A McPherson ,Maziar Divangahi ,Rachel E Niec ,Dana Pe'er ,Eugene Pietzak ,Steven Z Josefowicz ,Michael S Glickman

Intestinal mast cell-derived leukotrienes mediate the anaphylactic response to ingested antigens

肠道肥大细胞衍生的白三烯介导对摄入抗原的过敏反应

Nathaniel D Bachtel ,Jaime L Cullen ,Min Liu ,Steven A Erickson ,Vassily I Kutyavin ,Darine W El-Naccache ,Esther B Florsheim ,Jaechul Lim ,Zuri A Sullivan ,Raiden Imaeda ,Andrew Hudak ,Cuiling Zhang ,Ruslan Medzhitov

Activated T Cells Break Tumor Immunosuppression by Macrophage Reeducation

活化的T细胞通过巨噬细胞再教育打破肿瘤免疫抑制

Rosa Trotta ,Silvia Rivis # ,Shikang Zhao # ,Marie-Pauline Orban ,Sarah Trusso Cafarello ,Iris Charatsidou ,Joanna Pozniak ,Jonas Dehairs ,Lotte Vanheer ,Carlos A Pulido Vicuna ,Veerle Boecxstaens ,Oliver Bechter ,Francesca M Bosisio ,Johannes V Swinnen ,Jean-Christophe Marine ,Massimiliano Mazzone

Repair-associated macrophages increase after early-phase microglia attenuation to promote ischemic stroke recovery

早期小胶质细胞减少后,修复相关巨噬细胞数量增加,从而促进缺血性卒中后的恢复。

Xiaotao Zhang # ,Huaming Li # ,Yichen Gu # ,An Ping ,Jiarui Chen ,Qia Zhang ,Zhouhan Xu ,Junjie Wang ,Shenjie Tang ,Rui Wang ,Jianan Lu ,Lingxiao Lu ,Chenghao Jin ,Ziyang Jin ,Jianmin Zhang ,Ligen Shi

GLI2 Facilitates Tumor Immune Evasion and Immunotherapeutic Resistance by Coordinating WNT and Prostaglandin Signaling

GLI2通过协调WNT和前列腺素信号通路促进肿瘤免疫逃逸和免疫治疗耐药性

Nicholas C DeVito ,Y-Van Nguyen ,Michael Sturdivant ,Michael P Plebanek ,Kaylee A Villarreal ,Nagendra Yarla ,Vaibhav Jain ,Michael Aksu ,Georgia M Beasley ,Balamayooran Theivanthiran ,Brent A Hanks

Identification of anti-TIM-3 based checkpoint inhibitor combinations with activity in immunotherapy refractory melanoma models

鉴定在免疫疗法难治性黑色素瘤模型中具有活性的基于抗TIM-3的检查点抑制剂组合

Manali S Phadke ,Jiannong Li ,Sathya Sriramareddy ,Paulo C Rodriguez ,Brian Ruffell ,Vincent C Luca ,Thuy T T Tran ,Yian Ann Chen ,Keiran S M Smalley

Enhanced antitumor immunity of VNP20009-CCL2-CXCL9 via the cGAS/STING axis in osteosarcoma lung metastasis

VNP20009-CCL2-CXCL9通过cGAS/STING轴增强骨肉瘤肺转移的抗肿瘤免疫力

Ruixuan Liu # ,Qi Liu # ,Yuming Wang # ,Tianyi Liu ,Zhusheng Zhang ,Chong Zhao ,Haipeng Tao ,Elizabeth Ogando-Rivas ,Paul Castillo ,Weibin Zhang

Universal Fab-Fc masked cytokine prodrug platform: αPD-L1/IL-15 prodrug activates CD44+ CD8+ T cells in tumor-draining lymph nodes to enhance antitumor immunity

通用Fab-Fc掩蔽细胞因子前药平台:αPD-L1/IL-15前药激活肿瘤引流淋巴结中的CD44+CD8+T细胞,从而增强抗肿瘤免疫力

Luyao Song ,Gen Qi ,Wenqiang Shi ,Qiongya Zeng ,Ying Qin ,Zejian Wang ,Wei Li ,Zilan Song ,Ao Zhang ,Huili Lu

Restricting SLC7A5-mediated Leucine uptake in T cells prevents acute GVHD and maintains GVT response

限制T细胞中SLC7A5介导的亮氨酸摄取可预防急性移植物抗宿主病(GVHD)并维持移植物抗肿瘤(GVT)反应。

Nieves Fernández-Gallego # ,Blanca Anega # ,Susana Luengo-Arias ,Maider Bizkarguenaga ,Rubén Gil-Redondo ,Nieves Embade ,Laura Navarrete-Arias ,Marta Ramírez-Huesca ,Emigdio Álvarez-Corrales ,Sara G Dosil ,Raquel Castillo-González ,Amelia Rojas-Gomez ,Inés Espeleta ,Sara Martínez-Martínez ,Arantzazu Alfranca ,Virginia G de Yebenes ,Noa Beatriz Martín-Cófreces ,Julián Aragonés ,Pilar Martin ,Oscar Millet ,Francisco Sánchez-Madrid ,Danay Cibrian

Modulating tumor immunity using advanced microbiome therapeutics producing an indole metabolite.

利用产生吲哚代谢物的先进微生物组疗法调节肿瘤免疫

Vaaben Troels Holger, Lützhøft Ditte Olsen, Koulouktsis Andreas, Dawoodi Ida Melisa, Stavnsbjerg Camilla, Kvich Lasse, Gögenur Ismail, Vazquez-Uribe Ruben, Sommer Morten Otto Alexander
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14